Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D01YWD | ||||
| Former ID | DNC010399 | ||||
| Drug Name | 4-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula | C20H24FNO3 | ||||
| Canonical SMILES | CCCCOC1=CC=C(C=C1)C(CC)NC(=O)OC2=CC=C(C=C2)F | ||||
| InChI | 1S/C20H24FNO3/c1-3-5-14-24-17-10-6-15(7-11-17)19(4-2)22-20(23)25-18-12-8-16(21)9-13-18/h6-13,19H,3-5,14H2,1-2H3,(H,22,23) | ||||
| InChIKey | IEKBPHHXDXKATO-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
